Will Anthropic overtake Warren Buffett's Berkshire Hathaway in market cap on listing day?

Executive Brief • Key Highlights
Fast factual intelligence distilled for busy investors, executives, and answer bots:
- ✓Anthropic could overtake Warren Buffett's Berkshire Hathaway in market cap during its Nasdaq debut on November 19.
- ✓The AI firm targets a valuation up to $1.41 trillion.
- ✓Viram Shah said, "The proposed valuation is already substantial, and the stock's performance will depend on the final IPO pricing and institutional demand."
Story at a Glance
- Category
- Indian Markets
- Reported By
- Financial Express
- Reading Speed
- 6 Minute(s)
- Market Focus
- India Economy
Could Anthropic's IPO make it bigger than Warren Buffett's Berkshire Hathaway on its Nasdaq debut? On paper, yes. But the number that gets it there needs a closer look.
With a proposed valuation of up to $1.41 trillion, the AI company could rank among the world's most valuable listed companies from day one. It could potentially overtake Berkshire Hathaway in market capitalisation.
At the top of its proposed IPO price range ($70 to $78 per share), Anthropic is targeting a fully diluted valuation of roughly $1.26 trillion to $1.41 trillion ahead of its scheduled Nasdaq debut under the ticker ANT on November 19, 2026.
What does 'fully diluted' mean? It counts shares that could exist in the future, not only the shares in circulation today. At the top of the range, Anthropic would be valued at about $1.4 trillion on a fully diluted basis, which includes securities such as stock options and restricted stock. On a non-diluted basis, excluding those securities, Anthropic's market value would be about $1 trillion.
Unlock the Full Story with ArthNow Premium
To continue reading this complete financial story and in-depth market context, upgrade to ArthNow Premium. Enjoy unlimited access across Web and Mobile.
Financial Express
Read the full, original unfiltered story directly on the publisher's portal.
This brief is for information only and is not investment advice. ArthNow is not a SEBI-registered investment adviser and does not publish buy or sell recommendations. Original reporting is credited to the publisher named above. Read our editorial policy or report an error.